Life Science Investing ABVC BioPharma Reports US$1.03 Million in Total Licensing Revenues Collected in Q3 to Date, Highlighting High-Margin Business Model
Life Science Investing ABVC BioPharma Receives $450,000 in Licensing Payments From OncoX BioPharma in Q3 2025
Life Science Investing BioLite, Inc., an ABVC BioPharma Subsidiary, Receives $230,000 Milestone Payment from AiBtl, Advancing Botanical Drug Licensing Collaboration
Life Science Investing ABVC BioPharma Receives $100,000 Milestone Payment From ForSeeCon, Strengthening Vitargus Licensing Deal
Life Science Investing ABVC BioPharma, Inc. Reports 103% Year-Over-Year Asset Growth and Secures $350K in Post-Quarter Licensing Revenue in Q2 2025
Blackrock Announces Arrangements to Address Mailing of Meeting Materials Resulting from the Canada Post Strike
